Retinopathy of prematurity: screening and treatment in Costa Rica

Tabarez-Carvajal, Ana Catalina; Montes-Cantillo, Milagro; Unkrich, Kelly Hodson; Trivedi, Rupal H.; Peterseim, Mae Millicent W.

doi:10.1136/bjophthalmol-2016-310005

Cited by 16 publications

(9 citation statements)

References 16 publications

(5 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies conducted in high-income countries have shown that infants born at ≥32 weeks are not at risk for developing ROP and most infants born at >28 weeks who develop ROP have a mild disease that spontaneously regressed without treatment 9. The findings of the TR-ROP study were comparable to those from other developing countries and showed that more mature and heavier babies were at risk for severe ROP 10…”

Section: Discussionmentioning

confidence: 68%

Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units

et al. 2018

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 68%

Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units

et al. 2018

View full text Add to dashboard Cite

show abstract

“…In a study by Tabarez-Carvajal et al among 3018 premature infants, the incidence of stages 1, 2, 3, 4, and 5 was reported to be 8.34%, 8.78%, 1.9%, 0.03%, and 0.30%, respectively [ 33 ]. In another study by Abdel HA et al, the prevalence of ROP stage 1 was 10.4%, stage 2 was 5.2% and stage 3 was 3.45%, and none of the infants had ROP at stages 4 or 5 [ 34 ].…”

Section: Discussionmentioning

confidence: 99%

Prevalence and risk factors of retinopathy of prematurity in Iran: a systematic review and meta-analysis

et al. 2018

View full text Add to dashboard Cite

BackgroundRetinopathy of prematurity (ROP) refers to the developmental disorder of the retina in premature infants and is one of the most serious and most dangerous complications in premature infants. The prevalence of ROP in Iran is different in various parts of Iran and its prevalence is reported to be 1–70% in different regions. This study aims to determine the prevalence and risk factors of ROP in Iran.MethodsThis review article was conducted based on the preferred reporting items for systematic review and meta-analysis (PRISMA) protocols. To find literature about ROP in Iran, a comprehensive search was done using MeSH keywords in several online databases such as PubMed, Ovid, Science Direct, EMBASE, Web of Science, CINAHL, EBSCO, Magiran, Iranmedex, SID, Medlib, IranDoc, as well as the Google Scholar search engine until May 2017. Comprehensive Meta-analysis Software (CMA) Version 2 was used for data analysis.ResultsAccording to 42 studies including 18,000 premature infants, the prevalence of ROP was reported to be 23.5% (95% CI: 20.4–26.8) in Iran. The prevalence of ROP stages 1, 2, 3, 4 and 5 was 7.9% (95% CI: 5.3–11.5), 9.7% (95% CI: 6.1–15.3), 2.8% (95% CI: 1.6–4.9), 2.9% (95% CI: 1.9–4.5) and 3.6% (95% CI: 2.4–5.2), respectively. The prevalence of ROP in Iranian girls and boys premature infants was 18.3% (95% CI: 12.8–25.4) and 18.9% (95% CI: 11.9–28.5), respectively. The lowest prevalence of ROP was in the West of Iran (12.3% [95% CI: 7.6–19.1]), while the highest prevalence was associated with the Center of Iran (24.9% [95% CI: 21.8–28.4]). The prevalence of ROP is increasing according to the year of study, and this relationship is not significant (p = 0.181). The significant risk factors for ROP were small gestational age (p < 0.001), low birth weight (p < 0.001), septicemia (p = 0.021), respiratory distress syndrome (p = 0.036), intraventricular hemorrhage (p = 0.005), continuous positive pressure ventilation (p = 0.023), saturation above 50% (p = 0.023), apnea (p = 0.002), frequency and duration of blood transfusion, oxygen therapy and phototherapy (p < 0.05), whereas pre-eclampsia decreased the prevalence of ROP (p = 0.014).ConclusionConsidering the high prevalence of ROP in Iran, screening and close supervision by experienced ophthalmologists to diagnose and treat the common complications of pre-maturity and prevent visual impairment or blindness is necessary.

show abstract

“…El Salvador and Guatemala have less than 50% of provinces/regions implementing a programmme (Table 1). 2014, 19 and Colombia uses the national health information system (ASIS) to collect data on the number of live born babies with birth weight <1,999 g with a diagnosis of ROP; in 2014 it was 8.3%. 20 Some countries have assessed their ROP programme in a selected group of NICUs; in 7 units in Rio de Janeiro, Brazil in 2010 to identify the characteristics of preterm infants at risk of ROP, 21 in 6 units in Lima, Peru in 2012, 22 and in 32 units in Mexico in 2015.…”

Section: Plans and Programmesmentioning

confidence: 99%

Retinopathy of prematurity prevention, screening and treatment programmes: Progress in South America

Silva¹,

Zin²,

Gilbert

2019

Seminars in Perinatology

View full text Add to dashboard Cite

Retinopathy of prematurity (ROP) is the main cause of blindness and visual impairment in Latin America and prevention, detection and treatment have been a priority in the Region in the last two decades. There is progress in the number of eligible babies screened and treated in at least half of the countries with strong regulations on ROP, but screening is not yet available in all provinces in most.More effort is needed to increase national protocols and legislation, strengthening of services and human resources to cover all national provinces, telemedicine might be a promising strategy.

show abstract

Retinopathy of prematurity: screening and treatment in Costa Rica

Abstract: We provide comprehensive data of ROP care in Costa Rica allowing assessment and comparison of screening criteria and protocol.

Cited by 16 publications

References 16 publications

Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units

Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units

Prevalence and risk factors of retinopathy of prematurity in Iran: a systematic review and meta-analysis

Retinopathy of prematurity prevention, screening and treatment programmes: Progress in South America

Contact Info

Product

Resources

About